U.S. markets open in 3 hours 2 minutes
  • S&P Futures

    4,005.75
    +22.75 (+0.57%)
     
  • Dow Futures

    32,677.00
    +221.00 (+0.68%)
     
  • Nasdaq Futures

    12,721.00
    +32.50 (+0.26%)
     
  • Russell 2000 Futures

    1,781.30
    +20.60 (+1.17%)
     
  • Crude Oil

    68.54
    +0.90 (+1.33%)
     
  • Gold

    1,970.20
    -12.60 (-0.64%)
     
  • Silver

    22.58
    -0.07 (-0.29%)
     
  • EUR/USD

    1.0747
    +0.0021 (+0.19%)
     
  • 10-Yr Bond

    3.4810
    0.0000 (0.00%)
     
  • Vix

    23.35
    -2.16 (-8.47%)
     
  • GBP/USD

    1.2254
    -0.0019 (-0.16%)
     
  • USD/JPY

    132.3850
    +1.0900 (+0.83%)
     
  • Bitcoin USD

    28,170.76
    +19.98 (+0.07%)
     
  • CMC Crypto 200

    610.54
    +10.87 (+1.81%)
     
  • FTSE 100

    7,503.01
    +99.16 (+1.34%)
     
  • Nikkei 225

    26,945.67
    -388.12 (-1.42%)
     

Bristol Myers' Revlimid Takes A 32% Hit As Generics Keep Coming

Bristol Myers' Revlimid Takes A 32% Hit As Generics Keep Coming

Bristol's Revlimid took fewer than expected generic hits in the fourth quarter, resulting in a beat and a pop for BMY stock Thursday.